Search Results - Andreas Hallqvist

  • Showing 1 - 11 results of 11
Refine Results
  1. 1

    Successful Treatment with Selpercatinib for Ectopic Cushing’s Syndrome Due to Medullary Thyroid Cancer by Oskar Ragnarsson, Marta Piasecka, Andreas Hallqvist

    Published in Current Oncology (2022-05-01)
    Get full text
    Article


  2. 2

    Assessment of radiation pneumonitis and predictive factors in patients with locally advanced non-small cell lung cancer treated with chemoradiotherapy by Kerstin Gunnarsson, Louise Mövik, Niclas Pettersson, Anna Bäck, Jan Nyman, Andreas Hallqvist

    Published in Acta Oncologica (2024-10-01)
    Get full text
    Article


  3. 3

    Immune checkpoint blockade improves the activation and function of circulating mucosal-associated invariant T (MAIT) cells in patients with non-small cell lung cancer by Patrik Sundström, Nikita Dutta, William Rodin, Andreas Hallqvist, Sukanya Raghavan, Marianne Quiding Järbrink

    Published in OncoImmunology (2024-12-01)
    Get full text
    Article


  4. 4

    Assessing the prognostic value of KRAS mutation combined with tumor size in stage I-II non-small cell lung cancer: a retrospective analysis by Ella A. Eklund, Ella A. Eklund, Ella A. Eklund, Ali Mourad, Ali Mourad, Clotilde Wiel, Sama I. Sayin, Henrik Fagman, Henrik Fagman, Andreas Hallqvist, Andreas Hallqvist, Volkan I. Sayin, Volkan I. Sayin

    Published in Frontiers in Oncology (2024-05-01)
    Get full text
    Article


  5. 5

    Optimizing the Schedule of PARP Inhibitors in Combination with <sup>177</sup>Lu-DOTATATE: A Dosimetry Rationale by Andreas Hallqvist, Johanna Svensson, Linn Hagmarker, Ida Marin, Tobias Rydén, Jean-Mathieu Beauregard, Peter Bernhardt

    Published in Biomedicines (2021-10-01)
    Get full text
    Article


  6. 6

    32 Identification of predictive biomarkers of clinical response to PD-1 blockade in patients with advanced non-small cell lung cancer by Nikita Dutta, Ella Eklund, Levent Akyürek, Per Torstensson, Volkan Sayin, Anna Rohlin, Andreas Hallqvist, Sukanya Raghavan

    Published in Journal for ImmunoTherapy of Cancer (2023-11-01)
    Article


  7. 7

    Stereotactic body radiotherapy as metastasis-directed therapy in oligometastatic prostate cancer: a systematic review and meta-analysis of randomized controlled trials by Astrid E. Persson, Andreas Hallqvist, Louise Bjørn Larsen, Mette Rasmussen, Jonas Scherman, Per Nilsson, Hanne Tønnesen, Adalsteinn Gunnlaugsson

    Published in Radiation Oncology (2024-12-01)
    Get full text
    Article


  8. 8

    Combinatory analysis of immune cell subsets and tumor-specific genetic variants predict clinical response to PD-1 blockade in patients with non-small cell lung cancer by Nikita Dutta, Anna Rohlin, Anna Rohlin, Ella A. Eklund, Ella A. Eklund, Ella A. Eklund, Maria K. Magnusson, Frida Nilsson, Levent M. Akyürek, Per Torstensson, Volkan I. Sayin, Volkan I. Sayin, Anna Lundgren, Anna Lundgren, Andreas Hallqvist, Andreas Hallqvist, Sukanya Raghavan, Sukanya Raghavan

    Published in Frontiers in Oncology (2023-02-01)
    Get full text
    Article


  9. 9

    Distinct metastatic organotropism shapes prognosis in lung adenocarcinoma with brain metastasis by Sama I. Sayin, Sama I. Sayin, Ella A. Eklund, Ella A. Eklund, Ella A. Eklund, Kevin X. Ali, Kevin X. Ali, Jozefina J. Dzanan, Jozefina J. Dzanan, Moe Xylander, Martin Dankis, Martin Dankis, Per Lindahl, Per Lindahl, Volkan I. Sayin, Volkan I. Sayin, Andreas Hallqvist, Andreas Hallqvist, Clotilde Wiel

    Published in Frontiers in Oncology (2025-04-01)
    Get full text
    Article


  10. 10

    Comprehensive genetic variant analysis reveals combination of KRAS and LRP1B as a predictive biomarker of response to immunotherapy in patients with non-small cell lung cancer by Ella A. Eklund, Johanna Svensson, Louise Stauber Näslund, Maria Yhr, Sama I. Sayin, Clotilde Wiel, Levent M. Akyürek, Per Torstensson, Volkan I. Sayin, Andreas Hallqvist, Sukanya Raghavan, Anna Rohlin

    Get full text
    Article


  11. 11

    Monotherapy With Immune Checkpoint Blockade Improves Survival Outcomes in KRAS-Mutant but Not KRAS Wild-Type Metastatic Lung Adenocarcinoma: Validation From an Extended Swedish Coh... by Ella A. Eklund, MD, Sama I. Sayin, MD, PhD, Jonas Smith Jonsson, MD, Hannes van Renswoude, MD, Jan Nyman, MD, PhD, Andreas Hallqvist, MD, PhD, Clotilde Wiel, PhD, Volkan I. Sayin, PhD

    Published in JTO Clinical and Research Reports (2025-10-01)
    Get full text
    Article


Search Tools: